000 01263 a2200361 4500
005 20250512035634.0
264 0 _c19881222
008 198812s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-198812000-00013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCreagan, E T
245 0 0 _aRecombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cDec 1988
300 _a652-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xtherapeutic use
650 0 4 _aInterferon-gamma
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRecombinant Proteins
700 1 _aSchaid, D J
700 1 _aAhmann, D L
700 1 _aFrytak, S
773 0 _tAmerican journal of clinical oncology
_gvol. 11
_gno. 6
_gp. 652-9
856 4 0 _uhttps://doi.org/10.1097/00000421-198812000-00013
_zAvailable from publisher's website
999 _c3148045
_d3148045